July 23, 2026

New Data for Acquired Hypothalamic Obesity

Researchers found greater reductions in body mass index and participant-reported hunger scores with setmelanotide than with placebo, although adverse and serious adverse events were more frequent in the setmelanotide group; only one serious adverse event was considered treatment-related.

Conexiant

July 17, 2026

FDA Approves New Iohexol Vials

The approval includes additional 300 mg iodine/mL and 350 mg iodine/mL vial presentations.

Conexiant

July 17, 2026

Marcus Neuroscience Institute Reaches Treatment Milestone 

Early in the morning of June 16, inside the MRI suite at Marcus Neuroscience Institute, June Montagne held a pen and tried to draw a circle.

Baptist Health South Florida

July 17, 2026

A More Direct Route to Intervention: Baptist Health Expands Surgical Pathways for Drug-Resistant Epilepsy

For patients who continue to have seizures despite appropriate anti-seizure medication therapy, timely referral for surgical evaluation can change the trajectory of care.

Baptist Health South Florida

July 15, 2026

Neurodegenerative Mortality May Be Higher in NFL Players

The largest study of former National Football League players found excess persisted even after accounting for the lower overall mortality associated with elite athletic participation.

Conexiant

June 22, 2026

FDA Clears Olastrocel Trial Expansion

Additional patients with ongoing opioid use are being enrolled as Creative Medical prepares for potential Phase 3 discussions with the FDA.

Conexiant

June 19, 2026

Arteriovenous Malformations in Children: A Pediatric Neurosurgeons Perspective

This Neuroscience Grand Rounds session, led by Muhammad Osama, MD, provides a pediatric neurosurgeon’s perspective on arteriovenous malformations (AVMs) in children, rare but high-risk vascular lesions that can lead to seizures, neurological deficits, or life-threatening hemorrhage.

Phoenix Children's Medical Connection

June 19, 2026

$8M gift establishes new neurosciences clinic at UCI Health — Irvine

The nearly 15,000-square-foot facility will integrate multidisciplinary care, including neurology, neurosurgery, brain imaging, and physical medicine and rehabilitation.

UCI Health

June 15, 2026

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.

Conexiant

June 08, 2026

Nurses Face High Physical, Cognitive Load in Trauma Surgery

Qualitative interviews identified four themes involving emergency challenges and response, teamwork, psychological stress and coping, and professional growth needs in trauma surgery.

Conexiant